India's Bharat Biotech to produce additional 200 million COVID-19 vaccine doses per year

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi/

(Reuters) – India’s Bharat Biotech on Thursday said it would ramp up the production of its COVID-19 vaccine by an additional 200 million doses per year.

The additional doses of the vaccine, called Covaxin locally, would be manufactured at the company’s plant in Gujarat and would be available by the fourth quarter of 2021, the drugmaker said.

Source: Read Full Article